TrialThe British journal of surgery2021

Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status.

L Zetterlund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.